Jessica Stitt
About Jessica Stitt
Chief Financial Officer Role
Jessica Stitt currently serves as the Chief Financial Officer. Her role entails overseeing the company's financial operations, developing financial strategies, and ensuring compliance with financial regulations. She brings extensive experience in financial management, strategic planning, and operational leadership to her current position.
Educational Background
Jessica Stitt holds an MBA from Simmons School of Management. Prior to that, she earned a Bachelor of Arts degree from Saint Anselm College. Her strong educational background has provided her with a solid foundation in business management, financial principles, and strategic decision-making.
Previous Role at Gyroscope Therapeutics
Before her current position, Jessica Stitt served as the Chief Financial Officer at Gyroscope Therapeutics. In this role, she was responsible for steering the financial direction of the company, managing budgets, financial reporting, and ensuring financial health and sustainability of the organization.
Experience at MyoKardia
Jessica held the position of Vice President of Finance and Operations at MyoKardia, Inc. Her responsibilities included overseeing financial operations, optimizing financial performance, and providing leadership in financial planning and analysis.
Role at Theravance Biopharma
At Theravance Biopharma, Inc., Jessica worked as Vice President of Finance and Investor Relations. She was responsible for managing investor relations, handling financial communications, and ensuring alignment between the company’s financial objectives and investor expectations.
Finance Roles at Nektar Therapeutics, Alkermes, and Blue Cross Blue Shield
Jessica Stitt has also held various roles in finance at Nektar Therapeutics, Alkermes, and Blue Cross Blue Shield of Massachusetts. Her roles in these organizations further deepened her expertise in financial management, budget oversight, and operational finance.